| COVID-19 among US dialysis patients: risk factors and outcomes from a national dialysis provider CM Hsu, DE Weiner, G Aweh, DC Miskulin, HJ Manley, C Stewart, V Ladik, ... American Journal of Kidney Diseases 77 (5), 748-756. e1, 2021 | 236 | 2021 |
| Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease PA McCullough, KR Sandberg, S Borzak, MP Hudson, M Garg, HJ Manley American heart journal 144 (2), 226-232, 2002 | 227 | 2002 |
| Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider HJ Manley, CG Garvin, DK Drayer, GM Reid, WL Bender, TK Neufeld, ... Nephrology Dialysis Transplantation 19 (7), 1842-1848, 2004 | 223 | 2004 |
| Medication-related problems in ambulatory hemodialysis patients: a pooled analysis HJ Manley, CA Cannella, GR Bailie, WLS Peter American journal of kidney diseases 46 (4), 669-680, 2005 | 199 | 2005 |
| Factors associated with medication-related problems in ambulatory hemodialysis patients HJ Manley, ML McClaran, DK Overbay, MA Wright, GM Reid, WL Bender, ... American journal of kidney diseases 41 (2), 386-393, 2003 | 147 | 2003 |
| Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2‐year, randomized, controlled study AB Pai, A Boyd, J Depczynski, IM Chavez, N Khan, H Manley Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (12 …, 2009 | 129 | 2009 |
| Drug record discrepancies in an outpatient electronic medical record: frequency, type, and potential impact on patient care at a hemodialysis center HJ Manley, DK Drayer, M McClaran, W Bender, RS Muther Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (2 …, 2003 | 109 | 2003 |
| Medication-related problems in CKD KE Cardone, S Bacchus, MM Assimon, AB Pai, HJ Manley Advances in chronic kidney disease 17 (5), 404-412, 2010 | 107 | 2010 |
| Medication-related problem type and appearance rate in ambulatory hemodialysis patients HJ Manley, DK Drayer, RS Muther BMC nephrology 4, 1-7, 2003 | 105 | 2003 |
| Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach AB Pai, KE Cardone, HJ Manley, WLS Peter, R Shaffer, M Somers, ... Clinical Journal of the American Society of Nephrology 8 (11), 1988-1999, 2013 | 101 | 2013 |
| Immunogenicity of SARS-CoV-2 vaccine in dialysis E Lacson Jr, CP Argyropoulos, HJ Manley, G Aweh, AI Chin, LH Salman, ... Journal of the American Society of Nephrology 32 (11), 2735-2742, 2021 | 84 | 2021 |
| The clinical and economic impact of pharmaceutical care in end‐stage renal disease patients HJ Manley, CA Carroll Seminars in dialysis 15 (1), 45-49, 2002 | 72 | 2002 |
| Health‐related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: a 2‐year randomized, controlled study AB Pai, A Boyd, A Chavez, HJ Manley Hemodialysis International 13 (1), 72-79, 2009 | 68 | 2009 |
| Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis HJ Manley, GR Bailie, R Frye, LD Hess, MD McGoldrick Journal of the American Society of Nephrology 11 (7), 1310-1316, 2000 | 68 | 2000 |
| Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients HJ Manley, GR Bailie, RD Asher, G Eisele, RF Frye Peritoneal dialysis international 19 (1), 65-70, 1999 | 66 | 1999 |
| Vancomycin use in patients requiring hemodialysis: a literature review KE Pallotta, HJ Manley Seminars in dialysis 21 (1), 63-70, 2008 | 64 | 2008 |
| Intravenous vancomycin pharmacokinetics in automated peritoneal dialysis patients HJ Manley, GR Bailie, RF Frye, MD McGoldrick Peritoneal dialysis international 21 (4), 378-385, 2001 | 63 | 2001 |
| Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients over 6 months CM Hsu, DE Weiner, HJ Manley, GN Aweh, V Ladik, J Frament, ... Clinical Journal of the American Society of Nephrology 17 (3), 403-413, 2022 | 57 | 2022 |
| Automated peritoneal dialysis symposium: treatment of peritonitis in APD: pharmacokinetic principles HJ Manley, GR Bailie Seminars in dialysis 15 (6), 418-421, 2002 | 52 | 2002 |
| Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis HJ Manley, NM Allcock Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (7 …, 2003 | 43 | 2003 |
